Oncology News

In a retrospective cohort study, researchers found that Peruvian patients with advanced-stage hepatocellular carcinoma could undergo liver resection and maintain good outcomes, despite current management guidelines. The researchers suggest that clinicians in developing countries reconsider the guidelines to avoid section bias for treatment.  

Research on patients enrolled in the Barcelona Clinic Liver Cancer intermediate stage patient subclassification cohort showed that further classification of patients with untreated hepatocellular carcinoma may enable prediction of various stages of survival and disease burden, according to published findings.

Researchers found that stereotactic body radiotherapy and radiofrequency ablation were effective options for treating hepatocellular carcinoma. However, stereotactic body radiotherapy was more useful for larger tumors.

Immunicum AB announced that the Swedish Medical Products Agency and the ethics committee has approved the extension of their phase 1/2 IM-102 clinical trial of Intuvax, allowing up to six more patients to be enrolled and treated for hepatocellular carcinoma.

Researchers in China found that aggressive tumors were more likely to be found in younger patients who underwent liver transplantation for hepatocellular carcinoma, which led to an increased risk for recurrence vs. older patients.

ArQule, Inc. and Daiichi Sankyo, Inc. announced that enrollment of the phase 3 METIV-HCC clinical trial investigating tivantinib for the treatment of hepatocellular carcinoma is complete.

The FDA granted orphan drug designation to ARQ 087 for the treatment of patients with cholangiocarcinoma, according to a press release from the drug’s manufacturer.

SAN FRANCISCO — According to data presented at The Liver Meeting 2015, a national retrospective study of Veterans Affairs patients showed increasing incidence rates for cirrhosis and hepatocellular carcinoma in the U.S. A majority of the increases are due to hepatitis C virus infection.

Researchers found nonalcoholic fatty liver disease-associated hepatocellular carcinoma to be common and on the rise in the United States, according to data from a population-based study published in Hepatology.

Sampling portal venous blood via endoscopic ultrasound was found to be safe and feasible for counting circulating tumor cells in patients with pancreaticobiliary cancers, which may prove to be a valuable tool in diagnosing and guiding treatment for these cancers, according to recent study data.